A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart Disease

Launched by SHANGHAI 10TH PEOPLE'S HOSPITAL · Nov 7, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new approach to cardiac rehabilitation for patients with ischemic heart disease, which includes conditions like coronary heart disease and heart failure. The study will compare this new treatment, which includes various therapies such as early respiratory rehabilitation and exercise therapy, with traditional rehabilitation methods. The goal is to see how effective these new therapies are and how well patients can follow through with home rehabilitation compared to standard treatments.

To participate in the trial, you must be between 18 and 85 years old and have a diagnosis of ischemic heart disease. Women who are pregnant cannot take part. You will be excluded if you have certain serious conditions, like severe breathing problems or heart issues that could complicate your recovery. If you join the trial, you can expect to engage in different rehabilitation activities and receive support to help improve your heart health. This study is currently recruiting participants, so there is an opportunity to be part of an important advancement in cardiac care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged between 18 and 85 years old
• • Female subjects no pregnancy
• • The main admission diagnosis of ischemic heart disease (coronary heart disease, myocardial infarction, ischemic heart failure, etc.)
• • The need for cardiac rehabilitation treatment
• Exclusion Criteria:
• • acute respiratory distress syndrome (ARDS);
• • acute episode of COPD;
• • uncontrolled pulmonary infection;
• • acute heart failure; acute pulmonary embolism;
• • acute myocarditis/pericarditis;
• • severe arrhythmia (degree II or III atrioventricular block, atrial flutter, or atrial fibrillation);
• • sternotomy, rib fracture, thoracic deformity, or other neurological diseases that may affect respiratory muscles